Gastrointestinal bleeding (GIB) is a potentially dreadful bleeding complication in Glanzmann Thrombasthenia (GT) because it is usually diagnosed late, when a significant amount of blood has already been lost, it is challenging to treat and leads to frequent hospitalizations, need of blood- and platelet-transfusions and death. Several cases of severe GIB in patients with GT can be found in the literature. One common cause of occult GIB is gastrointestinal angiodysplasia (GIA), a digestive tract vascular malformation characterized by localized ectasia and thinning of mucosal vessels, linked to dysregulated neoangiogenesis.
However, a systematic evaluation specifically of the frequency and characteristics of GIB in GT, and its possible association with GIA, has never been carried out.
Aim of this study is to assess the prevalence and severity of GIB, its association with GIA and the therapeutic approach adopted for the treatment of GIB, in a large population of Glanzmann Thrombasthenia patients.
We are now performing a retrospective survey asking to all centers involved in the management of GT patients worldwide to contribute to this study by filling in an easy and short questionnaire on GIB in GT.
This is an official initiative of the EHA-SWG on Thrombocytopenia and Platelet Function Disorders in conjunction with the SSC Platelet Physiology of the ISTH (see full project description at the link under Current Projects).
To receive the protocol and CRF and for further information please contact Prof Paolo Gresele (paolo.gresele@unipg.it).